2BB score and signals
Spyre Therapeutics, Inc.’s current 2BB score is 4 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 7 | Very Low |
| Momentum | 53 | Stable |
| Financial strength | 33 | Weak |
| Quality | 100 | Very Strong |
| Risk | 38 | Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | Jan 1, 2013 |
| Employees | 125 |
| 52-week range | $21.01 – $110.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-17 | — | -0.8683 | — | $0.00 |
| 2026-11-05 | — | -0.8334 | — | $0.00 |
| 2026-08-06 | — | -0.7738 | — | $0.00 |
| 2026-05-05 | -0.74 | -0.6794 | $0.00 | $0.00 |
Related companies
